NICE 2000/ 059
Issued: 14th November 2002
PRESS RELEASE
World Diabetes Day: continued commitment to improve diabetes treatment from NICE
World Diabetes Day is an opportunity to raise awareness of this serious condition. Diabetes, particularly type 2 diabetes, is on the increase in England and Wales. In line with the Government's priorities for health, the work programme of National Institute for Clinical Excellence reflects the need for improved services and care for people with diabetes.
NICE has issued a range of guidance the treatment and care of people with type 2 diabetes, including:
- Guidance on the use of rosiglitazone (August 2000)
- Guidance on the use of pioglitazone (March 2001)
- Guidelines for Management of type 2 diabetes on:
- Retinopathy - screening and early management (February 2002)
- Renal disease - prevention and early management (February 2002)
- Management of blood glucose (September 2002)
- Management of blood pressure and blood lipids (October 2002)
NICE will continue to develop national evidence-based guidance for the NHS in England and Wales in this area including:
- Insulin pump therapy (February 2003)
- Long acting insulin analogues (December 2002)
- Patient education models (March 2003)
- Diagnosis and management of type 1 diabetes in children and adults (December 2003 children, January 2004 adults)
- Update of Management of type 2 diabetes series:
- Prevention and management of foot care (December 2003)
Further information on the on the above guidance can be found on the NICE website, direct links are provided in the notes for editors section below.
Andrew Dillon, Chief Executive, said: "It is not surprising that as the independent organisation responsible for providing national guidance on treatments and care for those using the NHS in England and Wales, diabetes has been high on the NICE work programme. We have produced 6 pieces of guidance on drugs and treatments relating to diabetes care, that together have the potential to impact on the lives of every person with type 2 diabetes in England and Wales.
"The guidance we have planned, alongside that which we have issued to date,
aims to support people with both type 1 and type 2 diabetes by helping to reduce
the complications diabetes can bring and enhance their quality of life."
Ends
Notes to Editors
About NICE
| 1. | NICE is part of the NHS. It is the independent organisation responsible for providing national guidance on treatments and care for those using the NHS in England and Wales. Its guidance is for healthcare professionals and patients and their carers to help them make decisions about treatment and healthcare. For further information about NICE you can visit www.nice.org.uk. | |
| 2. | NICE produces guidance in three areas of health: | |
|
||
| NICE also funds four enquiries that undertake research into the way patients are treated to identify ways of improving the quality of care (the investigations are known as confidential enquiries). | ||
| 3. | NICE guidance and recommendations are prepared by independent groups that include professionals working in the NHS and people who are familiar with the issues affecting patients and carers. | |
| NICE guidance on type 2 diabetes | ||
| 4. | Direct links to completed NICE guidance on type 2 diabetes can be found below: | |
|
|
|
| Management of type 2 diabetes series | ||
|
||
| 5. | Direct links to NICE guidance on diabetes under development can be found below: | |
|
||
|
Update of Management of type 2 diabetes series
|
||
|
|
||
| World Diabetes Day | ||
| 6. | World Diabetes Day takes place on Thursday 14th November. Further details can be obtained from Diabetes UK on 020 7424 1165. | |
